menu
    • menu

    Company profile for Soligenix

    NEW Drugs in Dev: 12
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    AbbVie Contract Manufacturing partners globally to develop, scale, and manufacture pharmaceutical products successfully.

    Virtual Booth

    Contact Supplier

    Topscience Biotech is a one-stop supplier of sodium hyaluronate//drug manufacturing license, CEP, GMP, DMF, and Form 41 certifications.

    Virtual Booth

    Contact Supplier

    Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Soligenix has specialized knowledge in the development of orphan and unmet medical need indications including preclinical, manufacturing, regulatory and clinical expertise. We are a late-stage biopharmaceutical company committed to developing and commercializing products to treat rare diseases where there is an unmet medical need. Soligenix has a number of Public Health programs, funded entirely by government grants and contra...
    Soligenix has specialized knowledge in the development of orphan and unmet medical need indications including preclinical, manufacturing, regulatory and clinical expertise. We are a late-stage biopharmaceutical company committed to developing and commercializing products to treat rare diseases where there is an unmet medical need. Soligenix has a number of Public Health programs, funded entirely by government grants and contracts, which focus on infectious disease and biodefense applications, including our most advanced vaccination program to prevent ricin poisoning.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    SoligenixUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    29 Emmons Drive Suite B-10 Princeton, NJ 08540
    Telephone
    Telephone
    609-538-8200
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.soligenix.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/soligenix-inc-/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/Soligenix_Inc

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Soligenix Seeks Funding to Develop Bundibugyo Ebola Vaccine
    Soligenix Seeks Funding to Develop Bundibugyo Ebola Vaccine

    08 Jun 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/soligenix-applying-for-vaccine-development-funding-for-bundibugyo-ebola-vaccine-302793388.html

    PR NEWSWIRE
    08 Jun 2026
    Share Share
    Vaccine Platform Shows Suitability Against Ebola Bundibugyo Virus
    Vaccine Platform Shows Suitability Against Ebola Bundibugyo Virus

    26 May 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/suitability-of-vaccine-platform-for-bundibugyo-virus-cause-of-the-ebola-outbreak-in-congo-302780813.html

    PR NEWSWIRE
    26 May 2026
    Share Share
    Soligenix Reports Q1 2026 Results and Recent Updates
    Soligenix Reports Q1 2026 Results and Recent Updates

    08 May 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/soligenix-announces-recent-updates-and-first-quarter-2026-financial-results-302766364.html

    PR NEWSWIRE
    08 May 2026
    Share Share
    Soligenix Reports Interim Phase 3 FLASH2 HyBryte Results
    Soligenix Reports Interim Phase 3 FLASH2 HyBryte Results

    28 Apr 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/soligenix-announces-interim-results-from-the-phase-3-flash2-trial-evaluating-hybryte-in-treatment-of-cutaneous-t-cell-lymphoma-302754503.html

    PR NEWSWIRE
    28 Apr 2026
    Share Share
    Clinical Results from HyBryte Comparative Study Against Valchlor
    Clinical Results from HyBryte Comparative Study Against Valchlor

    02 Apr 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/positive-clinical-results-from-hybryte-comparative-study-evaluating-hybryte-against-valchlor-in-the-treatment-of-cutaneous-t-cell-lymphoma-published-in-oncology-and-therapy-302732442.html

    PR NEWSWIRE
    02 Apr 2026
    Share Share
    Soligenix Receives Orphan Drug Designation for SGX945
    Soligenix Receives Orphan Drug Designation for SGX945

    26 Mar 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/soligenix-receives-orphan-drug-designation-from-the-european-commission-for-sgx945-for-the-treatment-of-behcets-disease-302725591.html

    PR NEWSWIRE
    26 Mar 2026
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search